ANGO Valuation
AngioDynamics Inc
$
9.540
- Overview
- Forecast
- Valuation
ANGO Relative Valuation
ANGO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ANGO is overvalued; if below, it's undervalued.
Historical Valuation
No Data
Competitors Valuation Multiple
The average P/S ratio for ANGO's competitors is 4.38, providing a benchmark for relative valuation. AngioDynamics Inc Corp (ANGO) exhibits a P/S ratio of 1.24, which is -71.59% above the industry average. Given its robust revenue growth of -4.23%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch
ALRS
Alerus Financial Corp
21.600
USD
-1.50%
ATRO
Astronics Corp
30.330
USD
-2.32%
SVRA
Savara Inc
2.890
USD
-7.81%
STOK
Stoke Therapeutics Inc
9.480
USD
-5.67%
LINC
Lincoln Educational Services Corp
21.720
USD
+1.54%
CLW
Clearwater Paper Corp
29.370
USD
-0.94%
EVLV
Evolv Technologies Holdings Inc
5.940
USD
+7.22%
FFIC
Flushing Financial Corp
12.280
USD
-3.38%
RYAM
Rayonier Advanced Materials Inc
4.015
USD
-5.31%
FMNB
Farmers National Banc Corp
13.465
USD
-1.36%
FAQ
Is AngioDynamics Inc (ANGO) currently overvalued or undervalued?
AngioDynamics Inc (ANGO) is now in the Undervalued zone, suggesting that its current forward PS ratio of 1.24 is considered Undervalued compared with the five-year average of 1.78. The fair price of AngioDynamics Inc (ANGO) is between 13.70 to 24.42 according to relative valuation methord. Compared to the current price of 9.75 USD , AngioDynamics Inc is Undervalued By 28.81% .
What is AngioDynamics Inc (ANGO) fair value?
How does ANGO's valuation metrics compare to the industry average?
What is the current P/B ratio for AngioDynamics Inc (ANGO) as of May 21 2025?
What is the current FCF Yield for AngioDynamics Inc (ANGO) as of May 21 2025?
What is the current Forward P/E ratio for AngioDynamics Inc (ANGO) as of May 21 2025?